Heather Hasson Sells 22,874 Shares of FIGS (NYSE:FIGS) Stock

by · The Cerbat Gem

FIGS, Inc. (NYSE:FIGS – Get Free Report) insider Heather Hasson sold 22,874 shares of the business’s stock in a transaction on Thursday, February 5th. The shares were sold at an average price of $10.56, for a total transaction of $241,549.44. Following the transaction, the insider directly owned 1,251,967 shares in the company, valued at approximately $13,220,771.52. The trade was a 1.79% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link.

FIGS Trading Down 2.5%

NYSE:FIGS opened at $10.47 on Wednesday. The company has a 50-day moving average price of $11.51 and a 200-day moving average price of $8.96. The stock has a market cap of $1.72 billion, a price-to-earnings ratio of 104.70 and a beta of 1.29. FIGS, Inc. has a 12 month low of $3.57 and a 12 month high of $12.50.

Institutional Investors Weigh In On FIGS

A number of institutional investors have recently made changes to their positions in the company. Assetmark Inc. purchased a new position in FIGS in the 3rd quarter worth approximately $35,000. Elevated Capital Advisors LLC purchased a new stake in FIGS during the 4th quarter valued at $45,000. Quarry LP increased its holdings in shares of FIGS by 1,876.3% in the 3rd quarter. Quarry LP now owns 7,846 shares of the company’s stock worth $52,000 after purchasing an additional 7,449 shares in the last quarter. Capstone Financial Advisors Inc. purchased a new position in shares of FIGS in the second quarter worth $56,000. Finally, Hudson Bay Capital Management LP bought a new position in shares of FIGS during the second quarter valued at $61,000. Hedge funds and other institutional investors own 92.21% of the company’s stock.

Wall Street Analysts Forecast Growth

FIGS has been the subject of a number of recent research reports. Weiss Ratings reissued a “hold (c-)” rating on shares of FIGS in a research report on Monday, December 29th. The Goldman Sachs Group raised their target price on shares of FIGS from $5.50 to $7.50 and gave the company a “sell” rating in a research note on Friday, January 30th. Zacks Research raised FIGS from a “hold” rating to a “strong-buy” rating in a research report on Friday, November 7th. Barclays upped their price target on FIGS from $9.00 to $11.00 and gave the stock an “equal weight” rating in a research note on Tuesday, January 6th. Finally, Telsey Advisory Group reaffirmed a “market perform” rating and set a $9.00 price objective (up previously from $7.00) on shares of FIGS in a research report on Monday, November 3rd. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, FIGS has an average rating of “Hold” and an average price target of $10.10.

Get Our Latest Research Report on FIGS

FIGS Company Profile

(Get Free Report)

FIGS, Inc operates as a direct-to-consumer designer and retailer of medical apparel and accessories. The company offers a range of products tailored to the needs of healthcare professionals, including scrub sets, lab coats, tops, bottoms, outerwear, footwear, and performance fabrics designed for comfort, durability, and antimicrobial protection. Through its e-commerce platform and a growing network of retail stores, FIGS provides customizable uniforms and accessories with a focus on innovative materials and functional design features such as four-way stretch fabrics, moisture-wicking technology, and multiple secure pockets.

Founded in 2013 by Heather Hasson and Trina Spear, FIGS set out to disrupt the traditional medical uniform market by emphasizing both form and function.

Read More